BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Biologics

FDA Greenlights Groundbreaking Gene Therapies for Sickle Cell Disease Treatment

Sickle cell disease is a group of inherited blood disorders affecting approximately 100,000 people in the U.S. It is most common in African Americans and, ...

December 08, 2023 | News

CRISPR Explores Future of Cell & Gene Therapy at 2024 GenScript Biotech Global Forum

Recently, the world's first CRISPR/Cas9 gene editing therapy received market approval in the UK. This significant achievement comes 11 years after the inve...

December 08, 2023 | News

Innovent Biologics and Synaffix Expand ADC Collaboration Amid Promising Phase 1 Results

The expanded deal builds on a previous agreement signed in June 2021, under which Innovent is granted to deploy Synaffix's ADC technologies on a targe...

December 07, 2023 | News

Biotium Launches New Line of Extensively Validated Primary Antibody Conjugates for Flow Cytometry

Biotium, a leading provider of innovative solutions for life science research, is thrilled to announce the launch of Biotium Choice primary antibody conjug...

December 06, 2023 | News

Nona Biosciences Announces Collaboration Agreement with Lycia Therapeutics

Lycia is using its proprietary lysosomal targeting chimeras (LYTACs) platform to discover and develop first-in-class therapeutics that degrade extracellula...

December 05, 2023 | News

FDA Clears CARsgen's CT071 for Relapsed/Refractory Multiple Myeloma

CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignan...

December 05, 2023 | News

China Pharma Completes Third-Party Testing for Dry Eye Therapeutic Device

According to a disclosure by the Shanghai Public Health Clinical Center on June 6, 2023, an epidemiological survey of DED showed that approximately 34...

November 30, 2023 | News

Bahrain Secures Latest Human Genome Sequencing Machine in the Middle East

The Chairman of the Supreme Council of Health, Lt. General Dr. Shaikh Mohammed bin Abdulla Al Khalifa, highlighted the ongoing efforts within the Nati...

November 30, 2023 | News

Merck Expands Newest Biologics Testing Center in Shanghai

Further develops its biosafety testing laboratories to meet local demand New labs complete 2nd phase of company’s € 29 million...

November 30, 2023 | News

Boehringer Ingelheim broadens immuno-oncology portfolio with T3 Pharma acquisition

Despite the significant transformation of the cancer treatment landscape by immunotherapies, long-term remissions only occur in 15-20% of cancer patients. ...

November 27, 2023 | News

Ark Biopharmaceutical's AK0610 gets NMPA IND approval for RSV antibody

This antibody drug is bioengineered based on a neutralizing antibody originally isolated from a recovered child from respiratory syncytial virus (RSV) infe...

November 24, 2023 | News

IASO Bio opens global CAR-T center in China for international MM patients.

As a biopharmaceutical company that engages in the R&D, production and sales of innovative cell drugs, IASO Bio is not only developing CAR-T therapies ...

November 24, 2023 | News

BeiGene and Ensem Therapeutics Partner to Advance CDK2 Inhibitor

“We are committed to developing novel molecules with the potential to transform the therapeutic landscape for cancer patients, and this partnership f...

November 23, 2023 | News

Ark Biopharma's AK0610 Receives NMPA IND Approval for RSV Neutralizing Antibody

It is anticipated to protect infants throughout an entire RSV season. ArkBio licensed the drug's intellectual properties from the Institute of Microb...

November 23, 2023 | News

Stay Connected